Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
808.00    -10.00 (-1.22%)
Bid:
811.00
Ask:
813.00
Spread: 2.00 (0.247%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

AGM Statement

12 May 2021 11:51

RNS Number : 4025Y
Savills PLC
12 May 2021
 

 

12 May 2021

SAVILLS PLC

("Savills" or "the Company")

Trading update

 

Ahead of its "virtual" Annual General Meeting (AGM) to be held at 12 noon today at Savills, Finsbury Circus House, 15 Finsbury Circus, London EC2M 7EE Savills plc, the international real estate advisor issues the following trading update:

 

· Our Less Transactional businesses have continued to perform well with progressive recovery in a number of transactional markets becoming evident. The strategy of retaining staffing levels through 2020 has positioned the Group well for recovery

· For the year to date, the Group has traded better than anticipated and comfortably ahead of the prior equivalent period. Residential markets, particularly in the UK and China have continued strongly; the Commercial Transaction business has benefited both from improving sentiment in many markets and from the completion of transactions which were postponed or delayed during the lockdowns of Q4 2020

· Subject to the impact of further waves of COVID infections, the Board is confident in its expectations for the full year

 

 

Mark Ridley, Chief Executive, commented:

 

"I am delighted that our strategy of maintaining full client service through the pandemic continues to prove successful and improving sentiment has enabled much of the business development activity undertaken before and during 2020 to begin to bear fruit. We have a strong balance sheet and are focused on continuing to develop our global businesses through the recovery period, keeping our staff and visitors safe and maintaining a first class service to our clients.

 

"Our Less Transactional businesses of Consultancy and Property Management have continued to perform well to date as clients have begun to review longer term strategies once more and management contracts won in 2020 have begun to translate into revenue.

 

"Our Transactional businesses have benefited from improving sentiment in most markets, although travel restrictions still represent an obstacle to cross-border capital deployment. In summary, the combination of solid trading in the less transactional service lines, improving transactional markets (including the completion of previously delayed transactions) and continued cost containment, has resulted in a markedly improved performance compared with the same period last year."

 

 

Trading Update

 

In the Asia Pacific region, recovery has been most evident throughout the period in Greater China. More recently we have seen significant improvements in Australia, Singapore and Korea, accelerated in part by business development activity undertaken pre-pandemic, and have a healthy near-term pipeline in Japan. Throughout the period, our substantial Property and Facilities Management business in the region performed well.

 

In the UK, our performance has been very strong, driven primarily by the continued high levels of activity in the residential markets (both private and institutional), our strength in less transactional service lines and signs of recovery in development markets. We have also benefited from a number of transactions which were delayed during lock down.

 

In Continental Europe and the Middle East, where Savills is more dependent upon transactional activity, performance has improved compared with the prior period with recovery now evident in the Middle East, Ireland, Germany and France in particular. The current outbreaks of COVID-19 in parts of the region mean that the trajectory of recovery remains less clear.

 

In North America, where the Group is substantially dependent upon leasing activity by corporate occupiers, our business performance was in line with our expectations but has not yet reached the levels of the same period last year. Given the strong national vaccination programme, pre-transaction activity levels indicate that corporates are beginning to give serious consideration to their longer term real estate needs, which is a precursor to improved transaction levels. We continue to anticipate progressive recovery through H2 2021.

 

Savills Investment Management has performed ahead of our expectations, albeit in an environment which remains challenging for the deployment of equity capital. Debt markets are more positive for alternative lenders, such as DRC Capital, as the traditional bank lenders have widened margins and tightened LTV covenants and investors seek increasing exposure to this asset class.

 

 

Outlook

 

Our Less Transactional businesses continue to provide a solid platform for the Group and our residential businesses have shown strong recovery, albeit that we expect activity to return to more normal levels, particularly in the UK, during the second half of the year compared with an unusually strong comparative period in 2020. Internationally, commercial investment markets are showing varying speeds of recovery and, subject to further pandemic outbreaks, we expect this trend to continue through the year, although cross-border activity will depend upon how soon travel and quarantine restrictions can be eased.

 

We are confident in the Group's position both to benefit from progressive recovery in transactional markets and to continue to execute our growth strategies. The Board remains confident in its expectations for 2021 as a whole.

 

We anticipate announcing the Group's Half Year Results for the six months to 30 June on 5 August 2021.

 

For further information, contact:

 

Savills 020 7409 8934

Mark Ridley, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

David Allchurch

Elizabeth Snow

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFSIEAIFLIL
Date   Source Headline
2nd Dec 202410:00 amRNSTotal Voting Rights
26th Nov 20243:34 pmRNSHolding(s) in Company
22nd Nov 20242:00 pmRNSAdditional Listing
15th Nov 20242:58 pmRNSHolding(s) in Company
14th Nov 20241:53 pmRNSHolding(s) in Company
13th Nov 20241:47 pmRNSHolding(s) in Company
12th Nov 20242:51 pmRNSDirector/PDMR Shareholding
12th Nov 20242:48 pmRNSHolding(s) in Company
11th Nov 20242:25 pmRNSHolding(s) in Company
1st Nov 202411:00 amRNSTotal Voting Rights
14th Oct 20249:52 amRNSDirector/PDMR Shareholding
4th Oct 20242:00 pmRNSAdditional Listing
1st Oct 202411:00 amRNSTotal Voting Rights
18th Sep 20242:43 pmRNSDirector Declaration
16th Sep 20243:50 pmRNSDirector Declaration
12th Sep 20241:47 pmRNSDirector/PDMR Shareholding
2nd Sep 202411:00 amRNSTotal Voting Rights
29th Aug 20242:24 pmRNSDirector/PDMR Shareholding
15th Aug 202411:00 amRNSBlock listing Interim Review
13th Aug 20243:17 pmRNSDirector/PDMR Shareholding
8th Aug 20247:00 amRNSHalf-year Report
1st Aug 202411:00 amRNSTotal Voting Rights
30th Jul 20242:11 pmRNSHolding(s) in Company
22nd Jul 20242:36 pmRNSBlock listing Interim Review
11th Jul 20244:26 pmRNSDirector/PDMR Shareholding
1st Jul 20249:27 amRNSTotal Voting Rights
20th Jun 202410:36 amRNSDirector/PDMR Shareholding
13th Jun 20241:37 pmRNSDirector/PDMR Shareholding
11th Jun 20244:42 pmRNSDirector/PDMR Shareholding
7th Jun 20244:01 pmRNSDirector/PDMR Shareholding
4th Jun 20242:43 pmRNSDirector/PDMR Shareholding
3rd Jun 202411:00 amRNSTotal Voting Rights
23rd May 20242:21 pmRNSDirector/PDMR Shareholding
17th May 20243:44 pmRNSDirector/PDMR Shareholding
15th May 20243:06 pmRNSResult of AGM
15th May 202410:02 amRNSAGM Statement
14th May 20248:00 amRNSDirector/PDMR Shareholding
2nd May 20248:28 amRNSTotal Voting Rights
26th Apr 20242:13 pmRNSDirector/PDMR Shareholding
26th Apr 202411:21 amRNSDirector Declaration
15th Apr 20243:42 pmRNSDirector/PDMR Shareholding
12th Apr 20245:12 pmRNSDirector/PDMR Shareholding
8th Apr 20243:47 pmRNSAnnual Report and AGM Notice
21st Mar 20248:17 amRNSDirector/PDMR Shareholding
19th Mar 20245:11 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSNon-Executive Director Appointment
14th Mar 20247:00 amRNSFinal Results
13th Mar 20241:37 pmRNSDirector/PDMR Shareholding
15th Feb 202410:00 amRNSBlock listing Interim Review
13th Feb 20246:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.